Genetic analysis of 22 candidate genes for hypertension in the Japanese population

Naoharu Iwai, Naomi Tago, Naomi Yasui, Yoshihiro Kokubo, Nozomu Inamoto, Hitonobu Tomoike, Keisuke Shioji

2004-06-01

Abstract:Objective We performed association studies between 118 single-nucleotide polymorphisms (SNPs) of 22 candidate genes (or gene family) and hypertension in a Japanese population.

What problem does this paper attempt to address?

A genome-wide association study identifies a novel candidate locus at the DLGAP1 gene with susceptibility to resistant hypertension in the Japanese population

Yasuo Takahashi,Keiko Yamazaki,Yoichiro Kamatani,Michiaki Kubo,Koichi Matsuda,Satoshi Asai

DOI: https://doi.org/10.1038/s41598-021-98144-z

IF: 4.6

2021-09-30

Scientific Reports

Abstract:Abstract Numerous genetic variants associated with hypertension and blood pressure are known, but there is a paucity of evidence from genetic studies of resistant hypertension, especially in Asian populations. To identify novel genetic loci associated with resistant hypertension in the Japanese population, we conducted a genome-wide association study with 2705 resistant hypertension cases and 21,296 mild hypertension controls, all from BioBank Japan. We identified one novel susceptibility candidate locus, rs1442386 on chromosome 18p11.3 ( DLGAP1 ), achieving genome-wide significance (odds ratio (95% CI) = 0.85 (0.81–0.90), P = 3.75 × 10 −8 ) and 18 loci showing suggestive association, including rs62525059 of 8q24.3 ( CYP11B2 ) and rs3774427 of 3p21.1 ( CACNA1D ). We further detected biological processes associated with resistant hypertension, including chemical synaptic transmission, regulation of transmembrane transport, neuron development and neurological system processes, highlighting the importance of the nervous system. This study provides insights into the etiology of resistant hypertension in the Japanese population.

multidisciplinary sciences
Meta-Analysis of Genome-Wide Association Studies Identifies Common Variants Associated with Blood Pressure Variation in East Asians

Norihiro Kato,Fumihiko Takeuchi,Yasuharu Tabara,Tanika N Kelly,Min Jin Go,Xueling Sim,Wan Ting Tay,Chien-Hsiun Chen,Yi Zhang,Ken Yamamoto,Tomohiro Katsuya,Mitsuhiro Yokota,Young Jin Kim,Rick Twee Hee Ong,Toru Nabika,Dongfeng Gu,Li-ching Chang,Yoshihiro Kokubo,Wei Huang,Keizo Ohnaka,Yukio Yamori,Eitaro Nakashima,Cashell E Jaquish,Jong-Young Lee,Mark Seielstad,Masato Isono,James E Hixson,Yuan-Tsong Chen,Tetsuro Miki,Xueya Zhou,Takao Sugiyama,Jae-Pil Jeon,Jian Jun Liu,Ryoichi Takayanagi,Sung Soo Kim,Tin Aung,Yun Ju Sung,Xuegong Zhang,Tien Yin Wong,Bok-Ghee Han,Shotai Kobayashi,Toshio Ogihara,Dingliang Zhu,Naoharu Iwai,Jer-Yuarn Wu,Yik Ying Teo,E Shyong Tai,Yoon Shin Cho,Jiang He

DOI: https://doi.org/10.1038/ng.834

IF: 30.8

2011-01-01

Nature Genetics

Abstract:Norihiro Kato and colleagues perform a meta-analysis of genome-wide association studies to identify common variants associated with blood pressure variation in east Asians. They identify five new genome-wide significant signals and replicate seven loci previously discovered in populations of European ancestry. We conducted a meta-analysis of genome-wide association studies of systolic (SBP) and diastolic (DBP) blood pressure in 19,608 subjects of east Asian ancestry from the AGEN-BP consortium followed up with de novo genotyping (n = 10,518) and further replication (n = 20,247) in east Asian samples. We identified genome-wide significant (P < 5 × 10−8) associations with SBP or DBP, which included variants at four new loci (ST7L-CAPZA1, FIGN-GRB14, ENPEP and NPR3) and a newly discovered variant near TBX3. Among the five newly discovered variants, we obtained significant replication in the independent samples for all of these loci except NPR3. We also confirmed seven loci previously identified in populations of European descent. Moreover, at 12q24.13 near ALDH2, we observed strong association signals (P = 7.9 × 10−31 and P = 1.3 × 10−35 for SBP and DBP, respectively) with ethnic specificity. These findings provide new insights into blood pressure regulation and potential targets for intervention.
Comparative and Functional Genomic Resource for Mechanistic Studies of Human Blood Pressure–Associated Single Nucleotide Polymorphisms

Manoj K. Mishra,Eugene Y. Liang,Aron M. Geurts,Paul W. L. Auer,Pengyuan Liu,Sridhar Rao,Andrew S. Greene,Mingyu Liang,Yong Liu

DOI: https://doi.org/10.1161/hypertensionaha.119.14109

IF: 9.8968

2020-01-01

Hypertension

Abstract:The objective of the current study is to use comparative and functional genomic analysis to help to understand the biological mechanism mediating the effect of single nucleotide polymorphisms (SNPs) on blood pressure. We mapped 26 585 SNPs that are in linkage disequilibrium with 1071 human blood pressure–associated sentinel SNPs to 9447 syntenic regions in the mouse genome. Approximately 21.8% of the 1071 linkage disequilibrium regions are located at least 10 kb from any protein-coding gene. Approximately 300 blood pressure–associated SNPs are expression quantitative trait loci for a few dozen known blood pressure physiology genes in tissues including specific kidney regions. Blood pressure–associated sentinel SNPs are significantly enriched for expression quantitative trait loci for blood pressure physiology genes compared with randomly selected SNPs (P<0.00023, Fisher exact test). Using a newly developed deep learning method and other methods, we identified SNPs that were predicted to influence the conservation of CTCF (CCCTC-binding factor) binding across cell types, transcription factor binding, mRNA splicing, or secondary structures of RNA including long noncoding RNA. The SNPs were more likely to be located in CTCF-binding regions than what would be expected from the whole genome (P=4.90×10−7, Pearson χ2test). One example synonymous SNP rs9337951 was predicted to influence the secondary structure of its host mRNA JCAD (junctional cadherin 5 associated) and was experimentally validated to influence JCAD protein expression. These findings provide an extensive comparative and functional genomic resource for developing experiments to test the functional significance of human blood pressure–associated SNPs in human cells and animal models.
ATP2B1 gene polymorphisms associated with resistant hypertension in the Japanese population

Yusuke Kobayashi,Keisuke Yatsu,Aiko Haruna,Rina Kawano,Moe Ozawa,Tatsuya Haze,Shiro Komiya,Shota Suzuki,Yuki Ohki,Akira Fujiwara,Sanae Saka,Nobuhito Hirawa,Yoshiyuki Toya,Kouichi Tamura

DOI: https://doi.org/10.1111/jch.14785

2024-03-04

Journal of Clinical Hypertension

Abstract:Single‐nucleotide polymorphisms (SNP) of ATP2B1 gene are associated with essential hypertension but their association with resistant hypertension (RHT) remains unexplored. The authors examined the relationship between ATP2B1 SNPs and RHT by genotyping 12 SNPs in ATP2B1 gene of 1124 Japanese individuals with lifestyle‐related diseases. Patients with RHT had inadequate blood pressure (BP) control using three antihypertensive drugs or used ≥4 antihypertensive drugs. Patients with controlled hypertension had BP controlled using ≤3 antihypertensive drugs. The association between each SNP and RHT was analyzed by logistic regression. The final cohort had 888 (79.0%) and 43 (3.8%) patients with controlled hypertension and RHT, respectively. Compared with patients homozygous for the minor allele of each SNP in ATP2B1, a significantly higher number of patients carrying the major allele at 10 SNPs exhibited RHT (most significant at rs1401982: 5.8% vs. 0.8%, p = .014; least significant at rs11105378: 5.7% vs. 0.9%, p = .035; most nonsignificant at rs12817819: 5.1% vs. 10%, p = .413). After multivariate adjustment for age, sex, systolic BP, and other confounders, the association remained significant for rs2681472 and rs1401982 (OR: 7.60, p

peripheral vascular disease
Comprehensive Assessment of the Association of WNK4 Polymorphisms with Hypertension: Evidence from a Meta-Analysis

Xiao-gang Guo,Jie Ding,Hui Xu,Tian-ming Xuan,Wei-quan Jin,Xiang Yin,Yun-peng Shang,Fu-rong Zhang,Jian-hua Zhu,Liang-rong Zheng

DOI: https://doi.org/10.1038/srep06507

IF: 4.6

2014-01-01

Scientific Reports

Abstract:The relationship between with-no-lysine [K] kinase 4 ( WNK4 ) gene polymorphisms and hypertension has been widely investigated, However, the studies yielded contradictory results. To evaluate these inconclusive findings comprehensively, we therefore performed a meta-analysis. Ten articles encompassing 16 independent case-control studies with 6089 hypertensive cases and 4881 normotensive controls were selected for this meta-analysis. Four WNK4 gene polymorphisms were identified (G1155942T, G1156666A, T1155547C and C6749T). The results showed statistically significant associations of G1155942T polymorphism (allelic genetic model: odds ration or OR = 1.62, 95% confidence interval or CI: 1.11–2.38, P = 0.01; dominant model: OR = 1.85, 95% CI: 1.07–3.19, P = 0.03) and C6749T polymorphism (allele contrast: OR = 2.04, 95% CI: 1.60–2.59, P <0.01; dominant model: OR = 2.04, 95%CI: 1.59–2.62, P <0.01; and homozygous model: OR = 5.01, 95% CI: 1.29–19.54, P = 0.02) with hypertension risk. However, neither C1155547T nor G1156666A was associated significantly with hypertension susceptibility. In conclusion, this meta-analysis suggested that WNK4 G1155942T and C6749T gene polymorphisms may contribute to the susceptibility and development of hypertension. Further well-designed studies with larger sample size are required to elucidate the association of WNK4 gene multiple polymorphisms with hypertension risk.
Abstract 040: Comparative Genomic Analysis and Functional Insights for Blood Pressure-Associated Single Nucleotide Polymorphisms

Yong Liu,Manoj Mishra,Eugene Liang,Aron Geurts,Paul W. Auer,Pengyuan Liu,Sridhar Rao,Andrew Greene,Mingyu Liang

DOI: https://doi.org/10.1161/hyp.74.suppl_1.040

IF: 9.8968

2019-01-01

Hypertension

Abstract:Genetic factors play an important role in the regulation of blood pressure (BP) and the development of hypertension. Recent genome-wide association studies (GWAS) in large cohorts have identified associations of hundreds of single nucleotide polymorphisms (SNPs) with human BP. Understanding the molecular function of these SNPs and linking them to BP regulation are among the most pressing challenges in BP research. Animal models, including mouse models, are essential tools for studying BP regulatory mechanisms. In this study, we performed a thorough analysis of the most comprehensive set of human BP-associated SNPs to date and experimental validation. We mapped 26,585 human BP-associated SNPs in 1,071 linkage disequilibrium (LD) regions to 9,447 syntenic regions in the mouse genome. 6,551 of these sites have the same nearest protein-coding genes in human and mouse. 87.0% (932) of the 1,071 LD regions do not contain any nonsynonymous SNP, including 21.8% (234) that are at least 10 kb from any protein-coding gene. Approximately 300 BP-associated SNPs are expression quantitative trait loci for a few dozen known BP physiology genes in tissues including specific kidney regions that are physiologically important for BP regulation. CCCTC-binding factors (CTCF) are essential for regulating long-distance actions of enhancers. Using a newly developed deep learning model, we identified 5 BP-associated SNPs that might influence the conservation of CTCF binding across 40 cell types, and two of them are predicted to have strong effect on CTCF binding. Using SpliceAI, a deep neural network model for predicting the effect of SNPs on mRNA splicing, we identified 19, 9, 22, and 13 SNPs that have a delta value of more than 0.2 for acceptor gain, acceptor loss, donor gain, and donor loss, respectively. Several SNPs are predicted to influence secondary structure of mRNAs and long noncoding RNAs. We experimentally validated that synonymous SNP rs9337951, predicted to influence the secondary structure of its host mRNA JCAD, influences JCAD protein expression. These findings provide novel insights into the potential functional significance of human BP-associated SNPs and form an extensive basis for developing experiments to test such significance in human cells and animal models.
Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals

S. Omori,Y. Tanaka,M. Horikoshi,A. Takahashi,K. Hara,H. Hirose,A. Kashiwagi,K. Kaku,R. Kawamori,T. Kadowaki,Y. Nakamura,S. Maeda

DOI: https://doi.org/10.1007/s00125-009-1397-5

IF: 8.2

2009-05-20

Diabetologia

Abstract:Aims/hypothesisAdditional susceptibility loci for type 2 diabetes have been identified by a meta-analysis of genome-wide association studies (GWASs) in European populations. To examine further the roles of these new loci, we performed a replication study for the association of these single-nucleotide polymorphism (SNP) loci with the disease in three independent Japanese populations.MethodsWe genotyped seven of the 11 SNPs that emerged in stage 2 of the meta-analysis for European GWASs (rs864745 in JAZF1, rs12779790 near CDC123/CAMK1D, rs7961581 near TSPAN8/LGR5, rs4607103 near ADAMTS9, rs10923931 in NOTCH2, rs1153188 near DCD and rs9472138 near VEGFA) for three independent Japanese populations (first set, 1,630 type 2 diabetes patients vs 1,064 controls; second set, 1,272 type 2 diabetes patients vs 856 controls; third set, 486 type 2 diabetes patients vs 936 controls) using a TaqMan assay. The association of the SNP loci in each population was analysed using a logistic regression analysis, adjusting for age, sex and BMI, and the data were evaluated by a meta-analysis.ResultsA meta-analysis for the three case–control studies identified a nominal association of rs864745 in JAZF1 with type 2 diabetes (OR 1.148, 95% CI 1.034–1.275, p = 0.0098, corrected p = 0.069). The association of other loci did not reach statistically significant levels (nominal p > 0.05).Conclusions/interpretationFrom these results the contribution of these seven loci in conferring susceptibility to type 2 diabetes is considered minor in the Japanese population, if they are present.

endocrinology & metabolism
Associations of combined genetic and lifestyle risks with hypertension and home hypertension

Masato Takase,Takumi Hirata,Naoki Nakaya,Tomohiro Nakamura,Mana Kogure,Rieko Hatanaka,Kumi Nakaya,Ippei Chiba,Ikumi Kanno,Kotaro Nochioka,Naho Tsuchiya,Akira Narita,Hirohito Metoki,Michihiro Satoh,Taku Obara,Mami Ishikuro,Hisashi Ohseto,Akira Uruno,Tomoko Kobayashi,Eiichi N. Kodama,Yohei Hamanaka,Masatsugu Orui,Soichi Ogishima,Satoshi Nagaie,Nobuo Fuse,Junichi Sugawara,Shinichi Kuriyama,Gen Tamiya,Atsushi Hozawa,Masayuki Yamamoto,the ToMMo investigators

DOI: https://doi.org/10.1038/s41440-024-01705-8

2024-06-25

Hypertension Research

Abstract:No study, to our knowledge, has constructed a polygenic risk score based on clinical blood pressure and investigated the association of genetic and lifestyle risks with home hypertension. We examined the associations of combined genetic and lifestyle risks with hypertension and home hypertension. In a cross-sectional study of 7027 Japanese individuals aged ≥20 years, we developed a lifestyle score based on body mass index, alcohol consumption, physical activity, and sodium-to-potassium ratio, categorized into ideal, intermediate, and poor lifestyles. A polygenic risk score was constructed with the target data ( n = 1405) using publicly available genome-wide association study summary statistics from BioBank Japan. Using the test data ( n = 5622), we evaluated polygenic risk score performance and examined the associations of combined genetic and lifestyle risks with hypertension and home hypertension. Hypertension and home hypertension were defined as blood pressure measured at a community-support center ≥140/90 mmHg or at home ≥135/85 mmHg, respectively, or self-reported treatment for hypertension. In the test data, 2294 and 2322 participants had hypertension and home hypertension, respectively. Both polygenic risk and lifestyle scores were independently associated with hypertension and home hypertension. Compared with those of participants with low genetic risk and an ideal lifestyle, the odds ratios for hypertension and home hypertension in the low genetic risk and poor lifestyle group were 1.94 (95% confidence interval, 1.34–2.80) and 2.15 (1.60–2.90), respectively. In summary, lifestyle is important to prevent hypertension; nevertheless, participants with high genetic risk should carefully monitor their blood pressure despite a healthy lifestyle.

peripheral vascular disease
INTRINSIC GENETIC FACTORS WERE INCONSISTENTLY REPORTED FOR HYPERTENSION: A SYSTEMATIC REVIEW OF GENOME-WIDE ASSOCIATION STUDIES

Ziyu Hao,Pingping Jia,Yize Chen,Joshua Ys Tran,Karen Kl Yiu,Kelvin Kf Tsoi

DOI: https://doi.org/10.1097/01.hjh.0001021164.96964.ae

IF: 4.9

2024-05-01

Journal of Hypertension

Abstract:Objective: Genome-wide association studies (GWAS) played a pivotal role in exploring the intrinsic genetic factors of hypertension. Hundreds of studies using various datasets demonstrated the causal relationship between single nucleotide polymorphisms (SNPs) and phenotypes for hypertension, but the SNPs were inconsistently found over the years. This study aims to review all SNPs and make a conclusive direction of using SNPs to predict the risk of hypertension. Design and method: A literature search was conducted in May 2023. Original GWAS that examined the phenotype BP, BPV, or hypertension-related SNPs or Locus, with significant level at P <10-4, were included in this review. Name of the dataset, ethnicity of participants, marker SNPs, loci, Allele(A1), minor allele frequency (MAF), beta or Odds Ratio (OR), Standard Error (SE), and P-value were extracted as the outcomes. SNPs that lack loci were matched with corresponding loci on FUMA GWAS, and the specific diseases related to the target locus were extracted from the NIH National Library of Medicine. Data visualization was conducted by Python. Results: A total of 8,451 studies were identified and 63 original studies reported significant hypertension-related SNPs or Locus were included in this analysis. A total of 2,637 SNPs from 572 loci were identified with a causal relationship to BP or hypertension. Eight SNPs from 7 loci were identified with a causal relationship to BPV. Rs381858 from chromosome 14 was the most popular SNP identified by eight original studies, and rs8096897 within C18orf1 from chromosome 18 had the largest OR of 12.87 for phenotype systolic BP. The figure plotted the top 100 SNPs arranged in descending order of effect size, after grouping SNPs with the same loci (Figure 1.) Conclusions: Only a small number of SNPs showed a significant impact on the phenotype of BP or hypertension. For those in the same loci, some SNPs exhibited a contradicting direction of interpretation. As hypertension is an early situation for different types of disease, such as cardiovascular or neurodegenerative diseases, inconclusive findings demonstrate that genome-wide association studies may not be suitable for the symptoms of chronic diseases, including hypertension.

peripheral vascular disease
Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

Kazuyoshi Ishigaki,Masato Akiyama,Masahiro Kanai,Atsushi Takahashi,Eiryo Kawakami,Hiroki Sugishita,Saori Sakaue,Nana Matoba,Siew-Kee Low,Yukinori Okada,Chikashi Terao,Tiffany Amariuta,Steven Gazal,Yuta Kochi,Momoko Horikoshi,Ken Suzuki,Kaoru Ito,Satoshi Koyama,Kouichi Ozaki,Shumpei Niida,Yasushi Sakata,Yasuhiko Sakata,Takashi Kohno,Kouya Shiraishi,Yukihide Momozawa,Makoto Hirata,Koichi Matsuda,Masashi Ikeda,Nakao Iwata,Shiro Ikegawa,Ikuyo Kou,Toshihiro Tanaka,Hidewaki Nakagawa,Akari Suzuki,Tomomitsu Hirota,Mayumi Tamari,Kazuaki Chayama,Daiki Miki,Masaki Mori,Satoshi Nagayama,Yataro Daigo,Yoshio Miki,Toyomasa Katagiri,Osamu Ogawa,Wataru Obara,Hidemi Ito,Teruhiko Yoshida,Issei Imoto,Takashi Takahashi,Chizu Tanikawa,Takao Suzuki,Nobuaki Sinozaki,Shiro Minami,Hiroki Yamaguchi,Satoshi Asai,Yasuo Takahashi,Ken Yamaji,Kazuhisa Takahashi,Tomoaki Fujioka,Ryo Takata,Hideki Yanai,Akihide Masumoto,Yukihiro Koretsune,Hiromu Kutsumi,Masahiko Higashiyama,Shigeo Murayama,Naoko Minegishi,Kichiya Suzuki,Kozo Tanno,Atsushi Shimizu,Taiki Yamaji,Motoki Iwasaki,Norie Sawada,Hirokazu Uemura,Keitaro Tanaka,Mariko Naito,Makoto Sasaki,Kenji Wakai,Shoichiro Tsugane,Masayuki Yamamoto,Kazuhiko Yamamoto,Yoshinori Murakami,Yusuke Nakamura,Soumya Raychaudhuri,Johji Inazawa,Toshimasa Yamauchi,Takashi Kadowaki,Michiaki Kubo,Yoichiro Kamatani

DOI: https://doi.org/10.1038/s41588-020-0640-3

IF: 30.8

2020-06-08

Nature Genetics

Abstract:The overwhelming majority of participants in current genetic studies are of European ancestry. To elucidate disease biology in the East Asian population, we conducted a genome-wide association study (GWAS) with 212,453 Japanese individuals across 42 diseases. We detected 320 independent signals in 276 loci for 27 diseases, with 25 novel loci (P < 9.58 × 10−9). East Asian–specific missense variants were identified as candidate causal variants for three novel loci, and we successfully replicated two of them by analyzing independent Japanese cohorts; p.R220W of ATG16L2 (associated with coronary artery disease) and p.V326A of POT1 (associated with lung cancer). We further investigated enrichment of heritability within 2,868 annotations of genome-wide transcription factor occupancy, and identified 378 significant enrichments across nine diseases (false discovery rate < 0.05) (for example, NKX3-1 for prostate cancer). This large-scale GWAS in a Japanese population provides insights into the etiology of complex diseases and highlights the importance of performing GWAS in non-European populations.

genetics & heredity
Interethnic Analyses of Blood Pressure Loci in Populations of East Asian and European Descent

Fumihiko Takeuchi,Masato Akiyama,Nana Matoba,Tomohiro Katsuya,Masahiro Nakatochi,Yasuharu Tabara,Akira Narita,Woei-Yuh Saw,Sanghoon Moon,Cassandra N. Spracklen,Jin-Fang Chai,Young-Jin Kim,Liang Zhang,Chaolong Wang,Huaixing Li,Honglan Li,Jer-Yuarn Wu,Rajkumar Dorajoo,Jovia L. Nierenberg,Ya Xing Wang,Jing He,Derrick A. Bennett,Atsushi Takahashi,Yukihide Momozawa,Makoto Hirata,Koichi Matsuda,Hiromi Rakugi,Eitaro Nakashima,Masato Isono,Matsuyuki Shirota,Atsushi Hozawa,Sahoko Ichihara,Tatsuaki Matsubara,Ken Yamamoto,Katsuhiko Kohara,Michiya Igase,Sohee Han,Penny Gordon-Larsen,Wei Huang,Nanette R. Lee,Linda S. Adair,Mi Yeong Hwang,Juyoung Lee,Miao Li Chee,Charumathi Sabanayagam,Wanting Zhao,Jianjun Liu,Dermot F. Reilly,Liang Sun,Shaofeng Huo,Todd L. Edwards,Jirong Long,Li-Ching Chang,Chien-Hsiun Chen,Jian-Min Yuan,Woon-Puay Koh,Yechiel Friedlander,Tanika N. Kelly,Wen Bin Wei,Liang Xu,Hui Cai,Yong-Bing Xiang,Kuang Lin,Robert Clarke,Robin G. Walters,Iona Y. Millwood,Liming Li,John C. Chambers,Jaspal S. Kooner,Paul Elliott,Pim van der Harst,Marie Loh,Zhengming Chen,Makoto Sasaki,Xiao-Ou Shu,Jost B. Jonas,Jiang He,Chew-Kiat Heng,Yuan-Tsong Chen,Wei Zheng,Xu Lin,Yik-Ying Teo,E-Shyong Tai,Ching-Yu Cheng,Tien Yin Wong,Xueling Sim,Karen L. Mohlke,Masayuki Yamamoto,Bong-Jo Kim,Tetsuro Miki,Toru Nabika,Mitsuhiro Yokota,Yoichiro Kamatani,Michiaki Kubo,Norihiro Kato

DOI: https://doi.org/10.1038/s41467-018-07345-0

IF: 16.6

2018-01-01

Nature Communications

Abstract:Blood pressure (BP) is a major risk factor for cardiovascular disease and more than 200 genetic loci associated with BP are known. Here, we perform a multi-stage genome-wide association study for BP ( max N = 289,038) principally in East Asians and meta-analysis in East Asians and Europeans. We report 19 new genetic loci and ancestry-specific BP variants, conforming to a common ancestry-specific variant association model. At 10 unique loci, distinct non-rare ancestry-specific variants colocalize within the same linkage disequilibrium block despite the significantly discordant effects for the proxy shared variants between the ethnic groups. The genome-wide transethnic correlation of causal-variant effect-sizes is 0.898 and 0.851 for systolic and diastolic BP, respectively. Some of the ancestry-specific association signals are also influenced by a selective sweep. Our results provide new evidence for the role of common ancestry-specific variants and natural selection in ethnic differences in complex traits such as BP.
PS 10-20 LACK OF FAMILY-BASED ASSOCIATION BETWEEN COMMON VARIATION IN WNK1 AND BLOOD PRESSURE LEVEL

Jianjun Mu,Yingxue Yang,Fuqiang Liu,Wen-Ling Zheng

DOI: https://doi.org/10.1097/01.hjh.0000500823.22667.23

IF: 4.9

2016-01-01

Journal of Hypertension

Abstract:Objective: WNK1 (With No-lysine Kinase 1) modulate numerous sodium transport related ion channels involved in regulation of blood pressure. Several studies indicated associations between the common variants of WNK1 gene and hypertension or blood pressure levels. However, the data are rare, which in Asian populations or in normotensive or pre-hypertensive subjects. Our aim was to detect whether the common variations in the WNK1 gene are potential contributors to individual variations in blood pressure in a family- based sample. Design and Method: 525 individuals from 116 families were selected from a rural community of Northern China. Five single nucleotide polymorphisms were selected from WNK1 gene. Single marker and haplotype analyses were conducted using the Family Based Association Test program. Results: No associations for the five WNK1 SNPs and the constructed haplotype blocks of WNK1 with blood pressure level reached nominal statistical significance. Conclusions: We concluded that although multiple candidate genes are involved in development of hypertension, the genetic polymorphism in WNK1 is not a major contributor to the observed variability in blood pressure and familial clustering risk of hypertension.
Genome-wide analysis of heart failure yields insights into disease heterogeneity and enables prognostic prediction in the Japanese population

Nobuyuki Enzan,Kazuo Miyazawa,Satoshi Koyama,Ryo Kurosawa,Hirotaka Ieki,Hiroki Yoshida,Fumie Takechi,Masashi Fukuyama,Ryosuke Osako,Kohei Tomizuka,Xiaoxi Liu,Kouichi Ozaki,Yoshihiro Onouchi,Koichi Matsuda,Yukihide Momozawa,Hiroyuki Aburatani,Yoichiro Kamatani,Takanori Yamaguchi,Hiroshi Akazawa,Koichi Node,Patrick Thomas Ellinor,Michael G Levin,Scott M Damrauer,Benjamin F Voight,Jacob Joseph,Yan V Sun,Chikashi Terao,Toshiharu Ninomiya,Issei Komuro,Kaoru Ito

DOI: https://doi.org/10.1101/2024.11.14.24317249

2024-11-15

Abstract:To understand the genetic basis of heart failure (HF) in the Japanese population, we performed genome-wide association studies (GWASs) comprising 16,251 all-cause HF cases, 4,254 HF with reduced ejection fraction cases, 7,154 HF with preserved ejection fraction cases, and 11,122 non-ischemic HF cases among 213,828 individuals and identified five novel loci. A subsequent cross-ancestry meta-analysis and multi-trait analysis of the GWAS data identified 19 novel loci in total. Among these susceptibility loci, a common non-coding variant in TTN (rs1484116) was associated with reduced cardiac function and worse long-term mortality. We leveraged the HF meta-GWASs along with cardiac function-related GWASs to develop a polygenic risk score (PRS) for HF. The PRS successfully identified early-onset HF and those with an increased risk of long-term HF mortality. Our results shed light on the shared and distinct genetic basis of HF between Japanese and European populations and improve the clinical value of HF genetics.

Cardiovascular Medicine
Blood pressure and urinary sodium excretion in relation to 16 genetic polymorphisms in the natriuretic peptide system in Chinese.

Bang-Chuan Hu,Yan Li,Ming Liu,Li-Hua Li,Chang-Sheng Sheng,Yi Zhang,Ji-Guang Wang

DOI: https://doi.org/10.1507/endocrj.EJ14-0104

2014-01-01

Endocrine Journal

Abstract:We systematically investigated the association between single nucleotide polymorphisms (SNPs) in the natriuretic peptide system (NPPA, NPPB, NPPC, NPRA, NPRC, and Corin genes) and blood pressure in a Chinese population. The study population was recruited from a mountainous area 500 km south of Shanghai from 2003 to 2009. Using the ABI SNapShot method, we first genotyped 951 subjects enrolled in 2005 for 16 SNPs and then the remaining 1355 subjects as validation for 5 SNPs selected from the primary study. Overall, the association of the studied genetic polymorphisms with blood pressure and urinary excretion of cations was weak or non-significant. However, in the primary study, there was significant (P-int=0.003) interaction between the rs198358 polymorphism and age in relation to diastolic blood pressure. After adjustment for covariates, diastolic blood pressure was significantly higher in the G allele carriers than AA homozygotes in 176 subjects aged 60 years or older (77.8 +/- 1.72 vs 73.9 +/- 1.54 mmHg, P=0.001). In the primary combined with validation studies, this interaction remained statistically significant (P-int=0.02). The odds ratio of hypertension for carrying the G allele versus AA homozygotes was 1.25 (95% CI: 1.03-1.52; P=0.03) in all subjects, and 0.85 (0.51-1.41; P=0.53), 1.30 (0.98-1.73; P=0.06), and 1.45 (0.95-2.22; P=0.08) in the subjects younger than 40 years, 40-59 years, and 60 years or older, respectively. Some of the genetic polymorphisms in the natriuretic peptide system might be associated with blood pressure. However, not only the size, but also the direction of the association may change with age.
A Novel Nucleotide Polymorphism of Renin Gene and Essential Hypertension

HASIMU Buaijiaer,Nakayama Tomohiro,CHANG Zu-heng,HU Da-yi

DOI: https://doi.org/10.3969/j.issn.1008-0392.2005.06.012

2005-01-01

Abstract:Objective To screen coding region of human renin gene to find new polymorphisms and investigate whether there are associations between new polymorphisms of renin gene and essential hypertension(EH).Methods Using the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) method, we isolated A single nucleotide polymorphism (SNP) in intron 4 (T+17int4G); We performed an association study using this SNP in 212 hypertensive patients and 209 age-matched normotensive (NT) subjects.Results Distribution of genotype frequency T+17int4G was not significantly different in the two groups.Conclusion T+17int4G SNP was not associated with EH.
Evidence for Association of Polymorphisms in CYP2J2 and Susceptibility to Essential Hypertension: CYP2J2 Gene Polymorphisms and Hypertension

Sheng-Nan Wu,Yi Zhang,Charles O. Gardner,Qi Chen,Yan Li,Gu-Liang Wang,Ping-Jin Gao,Ding-Liang Zhu

DOI: https://doi.org/10.1111/j.1469-1809.2007.00346.x

2007-01-01

Annals of Human Genetics

Abstract:Objective Evidence from animal models and human studies suggests that CYP2J2 plays a mechanistic role in the development of hypertension. The present study aims to investigate the potential genetic contribution of the CYP2J2 gene to the etiology of essential hypertension (EH) and individual blood pressure. Methods We selected eight polymorphisms in/or around the CYP2J2 gene and performed a case-control association study involving 841 Han Chinese subjects, including 415 unrelated hypertensives and 426 age-, gender- and area-matched normotensives. Results Three functionally identified variants (CYP2J2 *2, *7 and CYP2J2 *8) and SNP rs11572182 represented rare polymorphisms in Han Chinese. However, the difference in rs1155002 genotype distribution between hypertensive and healthy subjects was close to significance (P = 0.06) in the whole sample. Interestingly, significant evidence for an association with rs1155002 was found in females when stratified by gender. In females, the TT homozygote of rs1155002 seems to be a risk factor for hypertension (p = 0.014). In addition, ANOVA analysis suggested TT carriers had significantly higher systolic blood pressure (p = 0.016). The genotype frequencies for rs10493270, rs1180273 and rs1324491 revealed no statistically significant differences. Likewise, four-marker haplotype frequencies showed no significant differences between cases and controls. Conclusion Our data provide strong evidence that the CYP2J2 gene is a susceptibility factor for essential hypertension, especially in females, and influences individual systolic blood pressure in the Chinese Han population.
Lack of Family-Based Association Between Common Variations in WNK1 and Blood Pressure Level

Fuqiang Liu,Qiufang Lian,Jie Ren,Keyu Ren,Yang Wang,Dan Wang,Chao Chu,Lan Wang,Tongshuai Guo,Enqi Liu,Jianjun Mu,Zuyi Yuan

DOI: https://doi.org/10.12659/msm.890791

2014-01-01

Medical Science Monitor

Abstract:Background: WNK1 (With No-lysine Kinase 1) modulates numerous sodium transport-related ion channels involved in regulation of blood pressure. Several studies have indicated associations between the common variants of the WNK1 gene and hypertension or blood pressure levels. However, little data exists on Asian populations and normotensive or pre-hypertensive subjects. Our aim was to detect whether the common variations in the WNK1 gene are potential contributors to individual variations in blood pressure in a family-based sample.Material/Methods: 525 individuals from 116 families were selected from a rural community of Northern China. Five single-nucleotide polymorphisms were selected from the WNK1 gene. Single-marker and haplotype analyses were conducted using the Family-Based Association Test program.Results: Regretful, no associations for the 5 WNK1 SNPs and the constructed haplotype blocks of WNK1 with blood pressure level reached nominal statistical significance.Conclusions: We conclude that although multiple candidate genes are involved in development of hypertension, the genetic polymorphism in WNK1 is not a major contributor to the observed variability in blood pressure and familial clustering risk of hypertension.
An Extreme-Sib-pair Genome Scan for Genes Regulating Blood Pressure.

XP Xu,JJ Rogus,HA Terwedow,JH Yang,ZX Wang,CZ Chen,TH Niu,BY Wang,HQ Xu,S Weiss,NJ Schork,ZA Fang

DOI: https://doi.org/10.1086/302405

1999-01-01

The American Journal of Human Genetics

Abstract:Hypertension, a risk factor for many cardiovascular, cerebrovascular, and renal diseases, affects one in four Americans, at an annual cost of>$30 billion. Although genetic mutations have been identified in rare forms of hypertension, including Liddle syndrome and glucocorticoid-remediable aldosteronism, the abundance of plausible candidate genes and potential environmental risk factors has complicated the genetic dissection of more prevalent essential hypertension. To search systematically for chromosomal regions containing genes that regulate blood pressure, we scanned the entire autosomal genome by using 367 polymorphic markers. Our study population, selected from a blood-pressure screen of >200,000 Chinese adults, comprises rare but highly efficient extreme sib pairs (207 discordant, 258 high concordant, and 99 low concordant) and all but a single parent of these sibs. By virtue of the sampling design, the number of sib pairs, and the availability of genotyped parents, this study represents one of the most powerful of its kind. Although no regions achieved a 5% genomewide significance level, maximum LOD-score values were >2.0 (unadjusted P<.001) for regions containing five markers (D3S2387, D11S2019, D15S657, D16S3396, and D17S1303), in our primary analysis. Other promising regions identified through secondary analyses include loci near D4S3248, D7S2195, D10S1423, D20S470, D20S482, D21S2052, PAH, and AGT.
Evidence For Association Of Polymorphisms In Cyp2j2 And Susceptibility To Essential Hypertension

Sheng-Nan Wu,Yi Zhang,Charles O. Gardner,Qi Chen,Yan Li,Gu-Liang Wang,Ping-Jin Gao,Ding-Liang Zhu

DOI: https://doi.org/10.1111/j.1469-1809.2007.00346.x

2007-01-01

Annals of Human Genetics

Abstract:Objective Evidence from animal models and human studies suggests that CYP2J2 plays a mechanistic role in the development of hypertension. The present study aims to investigate the potential genetic contribution of the CYP2J2 gene to the etiology of essential hypertension (EH) and individual blood pressure.Methods We selected eight polymorphisms in/or around the CYP2J2 gene and performed a case-control association study involving 841 Han Chinese subjects, including 415 unrelated hypertensives and 426 age-, gender- and area-matched normotensives.Results Three functionally identified variants (CYP2J2 *2, *7 and CYP2J2 *8) and SNP rs11572182 represented rare polymorphisms in Han Chinese. However, the difference in rs1155002 genotype distribution between hypertensive and healthy subjects was close to significance (P = 0.06) in the whole sample. Interestingly, significant evidence for an association with rs1155002 was found in females when stratified by gender. In females, the TT homozygote of rs1155002 seems to be a risk factor for hypertension (p = 0.014). In addition, ANOVA analysis suggested TT carriers had significantly higher systolic blood pressure (p = 0.016). The genotype frequencies for rs10493270, rs1180273 and rs1324491 revealed no statistically significant differences. Likewise, four-marker haplotype frequencies showed no significant differences between cases and controls.Conclusion Our data provide strong evidence that the CYP2J2 gene is a susceptibility factor for essential hypertension, especially in females, and influences individual systolic blood pressure in the Chinese Han population.
[A Polymorphism of Kynureninase Gene in a Hypertensive Candidate Chromosomal Region is Associated with Essential Hypertension].

Yi Zhang,Kui-xing Zhang,Xin He,Wen-tao Yuan,Gu-liang Wang,Shou-yu Mao,Ping-jin Gao,Wei Huang,Ding-liang Zhu

DOI: https://doi.org/10.3760/j:issn:0253-3758.2005.07.002

2005-01-01

Abstract:OBJECTIVE:To identify single nucleotide polymorphisms (SNP) in the regulatory and coding regions of human kynureninase (KYNU) gene in a hypertensive candidate chromosomal region 2q14-q23 of Han Chinese, and to investigate the relationship between polymorphisms in KYNU and essential hypertension.METHODS:The SNPs in the promoter region and exons of the KYNU gene were detected by direct DNA sequencing. Genotyping of the nonsynonymous Lys412Glu (A/G) polymorphism was performed by DHPLC technology in 456 hypertensive patients and 430 normal controls.RESULTS:Sixteen SNP were identified in the KYNU gene, including 6 in the regulatory region and 2 in the coding region (both of them lead to substitution of amino acid). Significant differences between hypertensive patients and normal controls were observed for the distribution of alleles (chi(2) = 6.693, P = 0.035) and genotypes (chi(2) = 4.188, P = 0.041) of the Lys412Glu polymorphism in all subjects, and for the distribution of alleles in the subgroup of men (chi(2) = 4.424, P = 0.035).CONCLUSION:The Lys412Glu polymorphism of the KYNU gene in a hypertensive candidate chromosomal region is associated with essential hypertension in Han Chinese.

Genetic analysis of 22 candidate genes for hypertension in the Japanese population

A genome-wide association study identifies a novel candidate locus at the DLGAP1 gene with susceptibility to resistant hypertension in the Japanese population

Meta-Analysis of Genome-Wide Association Studies Identifies Common Variants Associated with Blood Pressure Variation in East Asians

Comparative and Functional Genomic Resource for Mechanistic Studies of Human Blood Pressure–Associated Single Nucleotide Polymorphisms

ATP2B1 gene polymorphisms associated with resistant hypertension in the Japanese population

Comprehensive Assessment of the Association of WNK4 Polymorphisms with Hypertension: Evidence from a Meta-Analysis

Abstract 040: Comparative Genomic Analysis and Functional Insights for Blood Pressure-Associated Single Nucleotide Polymorphisms

Replication study for the association of new meta-analysis-derived risk loci with susceptibility to type 2 diabetes in 6,244 Japanese individuals

Associations of combined genetic and lifestyle risks with hypertension and home hypertension

INTRINSIC GENETIC FACTORS WERE INCONSISTENTLY REPORTED FOR HYPERTENSION: A SYSTEMATIC REVIEW OF GENOME-WIDE ASSOCIATION STUDIES

Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

Interethnic Analyses of Blood Pressure Loci in Populations of East Asian and European Descent

PS 10-20 LACK OF FAMILY-BASED ASSOCIATION BETWEEN COMMON VARIATION IN WNK1 AND BLOOD PRESSURE LEVEL

Genome-wide analysis of heart failure yields insights into disease heterogeneity and enables prognostic prediction in the Japanese population

Blood pressure and urinary sodium excretion in relation to 16 genetic polymorphisms in the natriuretic peptide system in Chinese.

A Novel Nucleotide Polymorphism of Renin Gene and Essential Hypertension

Evidence for Association of Polymorphisms in CYP2J2 and Susceptibility to Essential Hypertension: CYP2J2 Gene Polymorphisms and Hypertension

Lack of Family-Based Association Between Common Variations in WNK1 and Blood Pressure Level

An Extreme-Sib-pair Genome Scan for Genes Regulating Blood Pressure.

Evidence For Association Of Polymorphisms In Cyp2j2 And Susceptibility To Essential Hypertension

[A Polymorphism of Kynureninase Gene in a Hypertensive Candidate Chromosomal Region is Associated with Essential Hypertension].